ACAAI: Gene-Editing Therapy Reduces Angioedema Attacks in Hereditary Angioedema
Reduction of 75 and 77 percent seen in estimated mean monthly attack rate with 25-mg, 50-mg NTLA-2002 versus placebo
FDA Appoints New Head of Medical Devices
Relationship Suggested Between Hyperhidrosis, Sensitive Skin
Sensitive skin occurred on body sites that were and were not affected by hyperhidrosis
Benzene Exposure Results From Benzoyl Peroxide Drug Product Use
Benzene concentrations detected in 111 over-the-counter BPO drug products that were tested, maintained at room temperature
Industry Payments Common for Physician Peer Reviewers of Top Journals
Peer reviewers in this study received $64.18 million in general payments between 2020 and 2022
Risk for Second Melanoma Up for Those With First Melanoma Diagnosis
Melanoma less common among racial and ethnic minorities, but they still have increased rate of second primary melanoma
Bimekizumab Safe, Efficacious Over Two Years for Hidradenitis Suppurativa
Clinically meaningful efficacy outcomes observed at one year maintained to two years of treatment
Long-Term Efficacy for Lebrikizumab Seen in Moderate, Severe Eczema
Long-term efficacy seen for lebrikizumab every two weeks or every four weeks in moderate-to-severe atopic dermatitis
Female Residents Underrepresented in High-Compensation Specialties
High-compensation surgical specialties experienced increase in the proportion of female applicants and matriculants from 2008 to 2022
Anti-CTAg Antibodies Identified in Stage I, II Melanoma
Specific antibodies against three tumor antigens identified as promising diagnostic biomarkers for early-stage melanomas
